Hi, it’s Ike in Boston. We’ve gotten some more insight into the ADHD drug shortages, which have been going on for over two ...
Personal independence payment claims for anxiety and depression have more than doubled since 2019, official statistics show ...
12h
India Today on MSNAlia Bhatt on ADHD diagnosis: My body starts heating up in social gatheringsActor Alia Bhatt has opened up about her ADHD and anxiety diagnosis. In a recent interview with Jay Shetty, she spoke about ...
For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant ...
(HealthDay News) — The prevalence of children’s behavioral and developmental disorders increased nationally from 2019 to 2022, with some conditions linked to caregivers’ mental well-being, according ...
Adderall is a commonly prescribed medication for attention deficit hyperactivity disorder (ADHD) and narcolepsy. It helps ...
A study of people who started ADHD stimulant treatment via telehealth vs in-person visits shows no difference in risk of new substance use disorders except for young adults age 26-34.
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...
Compare ADHD medications Vyvanse (lisdexamfetamine) vs. Concerta (methylphenidate). Understand their similarities and ...
Traditional discipline often fails for ADHD teens. Immediate consequences, positive reinforcement, and self-regulation skills ...
Cingulate (CING) released Phase 3 safety data for its lead asset CTx-1301 for the treatment of Attention Deficit Hyperactivity Disorder, ADHD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results